Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66 | 67 | 23 | 70 | 157 |
| Receivables | 30 | 28 | 22 | 18 | 11 |
| TOTAL | $96 | $94 | $45 | $88 | $170 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 2 | 2 | 0 | 0 | 0 |
| TOTAL | $2 | $2 | $0 | $0 | $0 |
| Total Assets | $97 | $96 | $45 | $88 | $170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12 | 11 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 105 | 87 | 59 | 81 | 64 |
| Accrued Expenses | 284 | 208 | 100 | 289 | 224 |
| TOTAL | $401 | $306 | $159 | $370 | $288 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 474 | 474 | 423 | 140 | 140 |
| TOTAL | $474 | $474 | $423 | $140 | $140 |
| Total Liabilities | $874 | $780 | $582 | $510 | $428 |
| Shareholders' Equity | |||||
| Common Shares | 2,913 | 2,913 | 2,913 | 2,913 | 2,913 |
| Retained earnings | -4,237 | -4,137 | -3,928 | -3,805 | -3,629 |
| Other shareholders' equity | 547 | 540 | 477 | 470 | 457 |
| TOTAL | $-777 | $-684 | $-537 | $-422 | $-258 |
| Total Liabilities And Equity | $97 | $96 | $45 | $88 | $170 |